,
,
44 3.2 Caractéristiques générales de la population ,
,
,
,
,
,
,
,
,
59 4.3 Effets de la bobine Double-Cône (DC) sur le fonctionnement cérébral ,
, , p.61
, Les modifications de la fonction cérébrale en rTMS standard et profonde, p.61
, Autres cibles et autres protocoles de stimulation
,
,
,
somatiques ainsi que de prélever le matériel biologique des patients (CRP ultra-sensible, glycémie, hormones thyroïdiennes, marqueurs de l'inflammation, profil pharmacogénétique métabolique?) pour enrichir les bases de données, vol.87 ,
, Site officiel de l'Organisation mondiale de la Santé
,
Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials, Psychol Med. janv, vol.44, issue.2, pp.225-264, 2014. ,
Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis, J Affect Disord, vol.187, pp.73-83, 2015. ,
Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand. 1 juin, vol.109, issue.s420, pp.21-28, 2004. ,
Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey, J Affect Disord. août, vol.45, issue.1-2, pp.19-30, 1997. ,
Should depression be managed as a chronic disease?, BMJ. 17 févr, vol.322, issue.7283, pp.419-440, 2001. ,
, DSM-5, p.12, 2018.
,
The inventory for depressive symptomatology (IDS): Preliminary findings, Psychiatry Res. 1 mai, vol.18, issue.1, pp.65-87, 1986. ,
A new depression scale designed to be sensitive to change, Br J Psychiatry J Ment Sci. avr, vol.134, pp.382-391, 1979. ,
Development of a rating scale for primary depressive illness, Br J Soc Clin Psychol. déc, vol.6, issue.4, pp.278-96, 1967. ,
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression, Biol Psychiatry. 1 sept, vol.54, issue.5, pp.573-83, 2003. ,
An inventory for measuring depression, Arch Gen Psychiatry. juin, vol.4, pp.561-71, 1961. ,
A biopsychosocial model as a guide for psychoeducation and treatment of depression, Depress Anxiety, vol.23, issue.5, pp.312-336, 2006. ,
The rise and fall of the biopsychosocial model, Br J Psychiatry J Ment Sci. juill, vol.195, issue.1, pp.3-4, 2009. ,
The need for a new medical model: a challenge for biomedicine, Science. 8 avr, vol.196, issue.4286, pp.129-165, 1977. ,
The « Biopsychosocial Model »: 40 years of application in Psychiatry, Psychiatr Psychiatr. juin, vol.28, issue.2, pp.107-117, 2017. ,
Treatment of pulmonary tuberculosis with hydrazide derivatives of isonicotinic acid, J Am Med Assoc, vol.150, issue.10, pp.973-80, 1952. ,
The treatment of depressive states with G 22355 (imipramine hydrochloride) ,
, Am J Psychiatry, vol.115, issue.5, pp.459-64, 1958.
The Biochemistry of Affective Disorders, Br J Psychiatry, vol.113, issue.504, pp.1237-64, 1967. ,
Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect, Lancet Lond Engl. 18 janv, vol.1, issue.7586, pp.132-138, 1969. ,
The catecholamine hypothesis of affective disorders: A review of supporting evidence, Am J Psychiatry, vol.122, issue.5, pp.509-531, 1965. ,
Monoamine theories of depression: historical impact on biomedical research, J Hist Neurosci, vol.21, issue.4, pp.366-92, 2012. ,
Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th Edn ,
From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder, Front Cell Neurosci, vol.11, p.305, 2017. ,
Neuroendocrine abnormalities associated with untreated first episode patients with major depressive disorder and bipolar disorder, Psychoneuroendocrinology. sept, vol.107, pp.119-142, 2019. ,
The role of the neuroendocrine and immune systems in the pathogenesis of depression, Pharmacol Rep PR, vol.66, issue.5, pp.776-81, 2014. ,
Effects of cortisol on cognition in major depressive disorder, posttraumatic stress disorder and borderline personality disorder -2014 Curt Richter Award Winner, Psychoneuroendocrinology. janv, vol.51, pp.282-95, 2015. ,
Peripheral thyroid dysfunction in depression, World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 1 févr, vol.7, pp.131-138, 2006. ,
Stress, and Depression: A Neurocognitive Model, JAMA Psychiatry. juill, vol.72, issue.7, pp.727-736, 2015. ,
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications, Neuroscience. 29 août, vol.246, pp.199-229, 2013. ,
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment, Curr Neuropharmacol, vol.14, issue.7, pp.732-774, 2016. ,
Inflammation and depression: a causal or coincidental link to the pathophysiology?, Acta Neuropsychiatr. févr, vol.30, issue.1, pp.1-16, 2018. ,
Chronobiological theories of mood disorder, Eur Arch Psychiatry Clin Neurosci. mars, vol.268, issue.2, pp.107-125, 2018. ,
Circadian clock and stress interactions in the molecular biology of psychiatric disorders. Curr Psychiatry Rep, vol.16, p.483, 2014. ,
Melatonin and its analogs in insomnia and depression, J Pineal Res. mai, vol.52, issue.4, pp.365-75, 2012. ,
MicroRNAs and depression, Neurobiol Dis. mai, vol.46, issue.2, pp.272-280, 2012. ,
Role of BDNF epigenetics in activity-dependent neuronal plasticity, Neuropharmacology. janv, vol.76, pp.709-727, 2014. ,
Epigenetic effect of chronic stress on dopamine signaling and depression, Genet Epigenetics, vol.5, pp.11-17, 2013. ,
DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls, PloS One, vol.10, issue.3, p.119061, 2015. ,
Monozygotic twins affected with major depressive disorder have greater variance in methylation than their unaffected co-twin, Transl Psychiatry. 11 juin, vol.3, p.269, 2013. ,
Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample, Psychol Med. mai, vol.41, issue.5, pp.997-1007, 2011. ,
Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation, Epigenetics, vol.10, issue.2, pp.135-176, 2015. ,
Antidepressant actions of histone deacetylase inhibitors, J Neurosci Off J Soc Neurosci. 16 sept, vol.29, issue.37, pp.11451-60, 2009. ,
Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures, J Neurosci Off J Soc Neurosci. 16 juin, vol.24, issue.24, pp.5603-5613, 2004. ,
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli, Neuron, vol.56, issue.3, pp.517-546, 2007. ,
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients, Mol Psychiatry. mars, vol.12, issue.3, pp.247-57, 2007. ,
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. avr, vol.22, issue.4, pp.239-58, 2012. ,
Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression, Mol Psychiatry, vol.23, issue.1, pp.133-175, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02355790
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment, Am J Hum Genet. mai, vol.78, issue.5, pp.804-818, 2006. ,
Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies, J Affect Disord. avr, vol.138, issue.1-2, pp.9-18, 2012. ,
Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies, J Affect Disord. sept, vol.117, issue.1-2, pp.1-17, 2009. ,
Brain grey matter abnormalities in medication-free patients with major depressive disorder: a metaanalysis, Psychol Med, vol.44, issue.14, pp.2927-2964, 2014. ,
Distinguishing between major depressive disorder and obsessive-compulsive disorder in children by measuring regional cortical thickness, Arch Gen Psychiatry. mai, vol.68, issue.5, pp.527-560, 2011. ,
Gray Matter Differences Between Healthy and Depressed Adolescents: A Voxel-Based Morphometry Study, J Child Adolesc Psychopharmacol. juin, vol.22, issue.3, pp.190-197, 2012. ,
Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group, Mol Psychiatry, vol.22, issue.6, pp.900-909, 2017. ,
, Brain Mediation of Obsessive-Compulsive Disorder Symptoms: Evidence From, vol.75
, Functional Brain Imaging Studies in the Human and Nonhuman Primate, Semin Clin Neuropsychiatry. janv, vol.1, issue.1, pp.32-47, 1996.
The neural substrates of affective processing in depressed patients treated with venlafaxine, Am J Psychiatry. janv, vol.160, issue.1, pp.64-75, 2003. ,
Brain metabolic changes associated with symptom factor improvement in major depressive disorder, Biol Psychiatry. 1 août, vol.50, issue.3, pp.171-179, 2001. ,
Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels, Pharmacol Biochem Behav. mars, vol.71, issue.3, pp.431-478, 2002. ,
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression, Brain Struct Funct. sept, vol.213, issue.1-2, pp.93-118, 2008. ,
Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders, Curr Opin Neurobiol. avr, vol.11, issue.2, pp.240-249, 2001. ,
Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of base line activation and neural response data, Am J Psychiatry. juill, vol.169, issue.7, pp.693-703, 2012. ,
Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies, BMC Psychiatry, vol.14, 2014. ,
Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions, Psychol Med. août, vol.23, issue.3, 1993. ,
,
Positron emission tomography imaging in depression: a neural systems perspective, Neuroimaging Clin N Am, vol.13, issue.4, pp.805-820, 2003. ,
Neural mechanisms of the cognitive model of depression, Nat Rev Neurosci, vol.06, issue.8, pp.467-77, 2011. ,
Molecular, Functional, and Structural Imaging of Major Depressive Disorder, Neurosci Bull. 3 mai, vol.32, issue.3, pp.273-85, 2016. ,
Repetitive transcranial magnetic stimulation for treatment resistant depression: Re-establishing connections, Clin Neurophysiol Off J Int Fed Clin Neurophysiol, vol.127, issue.11, pp.3394-405, 2016. ,
The human brain is intrinsically organized into dynamic, anticorrelated functional networks, Proc Natl Acad Sci U S A. 5 juill, vol.102, issue.27, pp.9673-9681, 2005. ,
Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence, Neurosci Res. sept, vol.50, issue.1, pp.1-11, 2004. ,
Resting-state functional connectivity in major depressive disorder: A review, Neurosci Biobehav Rev. sept, vol.56, pp.330-374, 2015. ,
, , 2019.
,
Toward the future of psychiatric diagnosis: the seven pillars of RDoC, BMC Med. 14 mai, vol.11, p.126, 2013. ,
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol, vol.17, issue.11, pp.696-707, 2007. ,
Quelle définition pour la dépression résistante ?, Presse Médicale. 1 mars, vol.45, issue.3, pp.323-331, 2016. ,
Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review, J Affect Disord, vol.257, pp.640-649, 2019. ,
Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans, Hum Brain Mapp. févr, vol.31, issue.2, pp.210-231, 2010. ,
Genetic differences in cytochrome P450 enzymes and antidepressant treatment response, J Psychopharmacol Oxf Engl. févr, vol.28, issue.2, pp.133-174, 2014. ,
Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations, Transl Psychiatry. mars, vol.6, issue.3, p.754, 2016. ,
Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression, Psychiatry Res. 28 févr, vol.231, issue.2, pp.134-174, 2015. ,
, Frontal alpha asymmetry as a diagnostic marker in depression: Fact or fiction? A metaanalysis
,
When at first you don't succeed: sequential strategies for antidepressant nonresponders, J Clin Psychiatry, vol.58, issue.13, pp.23-32, 1997. ,
Staging methods for treatment resistant depression. A systematic review, J Affect Disord. mars, vol.137, issue.1-3, pp.35-45, 2012. ,
Standardisation framework for the Maudsley staging method for treatment resistance in depression, BMC Psychiatry, vol.11, issue.1, p.100, 2018. ,
The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms, J Clin Psychiatry. juill, vol.70, issue.7, pp.952-959, 2009. ,
, Depression in adults: treatment and management | Guidance and guidelines | NICE
,
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care, Int J Psychiatry Clin Pract. juin, vol.16, issue.2, pp.77-84, 2012. ,
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder, Can J Psychiatry Rev Can Psychiatr. sept, vol.61, issue.9, pp.540-60, 2016. ,
Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy, Neurosci Bull. 28 déc, vol.33, issue.3, pp.339-386, 2016. ,
The effectiveness of electroconvulsive therapy in treatment-resistant depression: a naturalistic study, J ECT. juin, vol.24, issue.2, pp.141-146, 2008. ,
Contemporary use and practice of electroconvulsive therapy worldwide, Brain Behav. mai, vol.2, issue.3, pp.283-344, 2012. ,
A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatmentresistant depression, Med Devices Auckl NZ, vol.6, pp.17-35, 2013. ,
Deep Brain Stimulation in Psychiatry: Mechanisms, Models, and Next-Generation Therapies, Psychiatr Clin North Am. sept, vol.41, issue.3, pp.373-83, 2018. ,
Deep brain stimulation in mental health: Review of evidence for clinical efficacy, Aust N Z J Psychiatry, vol.49, issue.11, pp.979-93, 2015. ,
Effectiveness of psychotherapy for treatment-resistant depression: a meta-analysis and meta-regression ,
, Psychol Med. févr, vol.49, issue.3, pp.366-79, 2019.
Non-invasive magnetic stimulation of human motor cortex, Lancet Lond Engl. 11 mai, vol.1, issue.8437, pp.1106-1113, 1985. ,
Traitement de la dépression par stimulation magnétique transcrânienne (rTMS) : quelles pistes pour le remboursement d'une activité de pointe en psychiatrie ?, Rev DÉpidémiologie Santé Publique. 1 mars, vol.65, 2017. ,
Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs, Brain Stimulat. janv, vol.6, issue.1, pp.1-13, 2013. ,
Effects of coil design on delivery of focal magnetic stimulation, Electroencephalogr Clin Neurophysiol. avr, vol.75, issue.4, pp.350-357, 1990. ,
Localized stimulation of neural tissues in the brain by means of a paired configuration of time-varying magnetic fields, J Appl Phys, vol.15, issue.10, pp.5862-5866, 1988. ,
The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder, Brain Stimulat, vol.9, issue.3, pp.336-382, 2016. ,
Transcranial magnetic stimulation (TMS) in basic and clinical neuroscience research ,
, Rev Neurol (Paris). avr, vol.167, issue.4, pp.291-316, 2011.
Comparison of the induced fields using different coil configurations during deep transcranial magnetic stimulation, Disponible sur, vol.12, 2017. ,
Theta-burst stimulation: a new form of TMS treatment for depression?, Depress Anxiety. mars, vol.32, issue.3, pp.182-92, 2015. ,
Theta burst stimulation of the human motor cortex, Neuron. 20 janv, vol.45, issue.2, pp.201-207, 2005. ,
Variability in Response to Quadripulse Stimulation of the Motor Cortex, Brain Stimulat. déc, vol.9, issue.6, pp.859-66, 2016. ,
Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research, Clin Neurophysiol Off J Int Fed Clin Neurophysiol. déc, vol.120, issue.12, pp.2008-2047, 2009. ,
Minimal heating of aneurysm clips during repetitive transcranial magnetic stimulation, Clin Neurophysiol Off J Int Fed Clin Neurophysiol. juill, vol.123, issue.7, pp.1471-1474, 2012. ,
Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression, Disponible sur, vol.79 ,
Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex, Brain J Neurol. août, vol.117, pp.847-58, 1994. ,
Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmacoresistant depression using either high-frequency left or low-frequency right prefrontal rTMS, Prog Neuropsychopharmacol Biol Psychiatry. 3 déc, vol.39, issue.2, pp.364-70, 2012. ,
Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century, J Neuropsychiatry Clin Neurosci, vol.8, issue.4, pp.373-82, 1996. ,
Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients, Psychiatry Res. 20 août, vol.115, issue.1-2, pp.1-14, 2002. ,
Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients, Biol Psychiatry. 15 déc, vol.48, issue.12, pp.1133-1174, 2000. ,
Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS, J Neuropsychiatry Clin Neurosci, vol.11, issue.4, pp.426-461, 1999. ,
Synchronization of neuronal activity in the human primary motor cortex by transcranial magnetic stimulation: an EEG study, J Neurophysiol, vol.86, issue.4, pp.1983-90, 2001. ,
Neuroanatomical correlates of therapeutic efficacy of lowfrequency right prefrontal transcranial magnetic stimulation in treatment-resistant depression, Psychiatry Clin Neurosci. mars, vol.65, issue.2, pp.175-82, 2011. ,
Hemispheric lateralization of functions related to emotion, Brain Cogn. juill, vol.5, issue.3, pp.322-53, 1986. ,
Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression, J Psychiatry Neurosci. juill, vol.29, issue.4, pp.268-79, 2004. ,
A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition, Clin Neurophysiol Off J Int Fed Clin Neurophysiol. déc, vol.117, issue.12, pp.2584-96, 2006. ,
Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression, Psychol Med. janv, vol.33, issue.1, pp.33-40, 2003. ,
Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study, Int J Neuropsychopharmacol. févr, vol.13, issue.1, pp.45-59, 2010. ,
Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients, Eur Psychiatry J Assoc Eur Psychiatr, vol.27, issue.7, pp.513-520, 2012. ,
Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and metaanalysis comparing the recent vs. the earlier rTMS studies, Acta Psychiatr Scand. sept, vol.116, issue.3, pp.165-73, 2007. ,
Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials, Depress Anxiety. juill, vol.30, issue.7, pp.614-637, 2013. ,
The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression, Psychoneuroendocrinology. 1 avr, vol.28, issue.3, pp.376-85, 2003. ,
, DEPRESSION: A SYSTEMATIC REVIEW. Depress Anxiety. déc, vol.32, issue.12, pp.871-91, 2015.
Baseline Brain Metabolism in Resistant Depression and Response to Transcranial Magnetic Stimulation, Neuropsychopharmacology. déc, vol.36, issue.13, pp.2710-2719, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00671239
Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression, Eur J Nucl Med Mol Imaging. sept, vol.38, issue.9, pp.1715-1737, 2011. ,
Use of a Double-Cone Coil in Transcranial Magnetic Stimulation for Depression Treatment, Neuromodulation J Int Neuromodulation Soc. 2 déc, 2018. ,
A Comprehensive Review of Dorsomedial Prefrontal Cortex rTMS Utilizing a Double Cone Coil, Neuromodulation J Int Neuromodulation Soc, 2018. ,
Application of transcranial magnetic stimulation for major depression: Coil design and neuroanatomical variability considerations, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 5 juill, 2019. ,
Efficacy of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-Coil in treatment of major depressive disorder; A randomized clinical trial, J Psychiatr Res. juill, vol.114, pp.113-122, 2019. ,
The ACDC Pilot Trial: Targeting the Anterior Cingulate by Double Cone Coil rTMS for the Treatment of Depression, Brain Stimul Basic Transl Clin Res Neuromodulation. 1 mars, vol.8, issue.2, pp.240-246, 2015. ,
Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol, vol.26, issue.7, pp.1213-1239, 2016. ,
Number of pulses or number of sessions? An open-label study of trajectories of improvement for once-vs. twice-daily dorsomedial prefrontal rTMS in major depression, Brain Stimulat. avr, vol.11, issue.2, pp.327-363, 2018. ,
Resting-State Cortico-Thalamic-Striatal Connectivity Predicts Response to Dorsomedial Prefrontal rTMS in Major Depressive Disorder, Neuropsychopharmacology. janv, vol.39, issue.2, pp.488-98, 2014. ,
rTMS of the Dorsomedial Prefrontal Cortex for Major Depression: Safety, Tolerability, Effectiveness, and Outcome Predictors for 10 Hz Versus Intermittent Theta-burst Stimulation, Brain Stimulat. 1 mars, vol.8, issue.2, pp.208-223, 2015. ,
Effects of Hesel-coil deep transcranial magnetic stimulation for depression -a systematic review, Nord J Psychiatry, vol.70, issue.7, pp.492-499, 2016. ,
Hertfordshire Neuroscience Research group. Defining remission by cut off score on the MADRS: selecting the optimal value, J Affect Disord, vol.72, issue.2, pp.177-84, 2002. ,
The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients, Acta Psychiatr Scand Suppl, vol.334, pp.1-100, 1987. ,
18 F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI), Cochrane Database Syst Rev. 28 janv, vol.1, p.10632, 2015. ,
Fluorodeoxyglucose-Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis, Am J Neuroradiol. 1 févr, vol.30, issue.2, pp.404-414, 2009. ,
SPECT-PET in Epilepsy and Clinical Approach in Evaluation, Semin Nucl Med, vol.46, issue.4, pp.294-307, 2016. ,
Presurgical Focus Localization in Epilepsy: PET and SPECT, Semin Nucl Med. janv, vol.47, issue.1, pp.44-53, 2017. ,
FDG-PET hyperactivity pattern in anti-NMDAr encephalitis, J Neuroimmunol, vol.15, pp.156-164, 2016. ,
Diagnostic Value of 18F-FDG PET/CT Versus MRI in the Setting of Antibody-Specific Autoimmune Encephalitis, J Nucl Med Off Publ Soc Nucl Med, vol.58, issue.8, pp.1307-1320, 2017. ,
Clinical applications of PET in brain tumors, J Nucl Med Off Publ Soc Nucl Med. sept, vol.48, issue.9, pp.1468-81, 2007. ,
Neuroimaging in psychiatry: an update on neuroimaging in the clinical setting, Australas Psychiatry Bull R Aust N Z Coll Psychiatr. avr, vol.24, issue.2, pp.157-63, 2016. ,
Computational neuroscience approach to biomarkers and treatments for mental disorders, Psychiatry Clin Neurosci. avr, vol.71, issue.4, pp.215-252, 2017. ,
Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder, J Affect Disord, vol.233, pp.21-35, 2018. ,
Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping, NeuroImage. janv, vol.9, issue.1, pp.63-80, 1999. ,
Maintenance transcranial magnetic stimulation reduces depression relapse: A propensity-adjusted analysis, J Affect Disord. 18 juin, p.151, 2013. ,
Comparison of « standard » and « navigated » procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression, Neurophysiol Clin Clin Neurophysiol. mars, vol.40, issue.1, pp.27-36, 2010. ,
The value of neuronavigated rTMS for the treatment of depression, Neurophysiol Clin Clin Neurophysiol. mars, vol.40, issue.1, pp.37-43, 2010. ,
Comparison of navigated and non-navigated transcranial magnetic stimulation for motor cortex mapping, motor threshold and motor evoked potentials, NeuroImage. 1 févr, vol.44, issue.3, pp.790-795, 2009. ,
Cognitive impairment from early to middle adulthood in patients with affective and nonaffective psychotic disorders, Psychol Med. 4 janv, pp.1-10, 2019. ,
A review of the role of social cognition in major depressive disorder, Front Psychiatry, vol.5, p.179, 2014. ,
Diagnosis and treatment of depression and cognitive impairment in late life, Ann N Y Acad Sci. mai, vol.1345, pp.36-46, 2015. ,
Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and metaanalysis, BMC Psychiatry. 7 mai, vol.19, issue.1, p.139, 2019. ,
Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression, Biol Psychiatry. 1 août, vol.76, issue.3, pp.176-85, 2014. ,
HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging, CNS Spectr. août, vol.14, issue.8, pp.439-487, 2009. ,
Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism, J Affect Disord. déc, vol.127, issue.1-3, pp.219-248, 2010. ,
Parietal cortex and representation of the mental Self, Proc Natl Acad Sci U S A. 27 avr, vol.101, issue.17, pp.6827-6859, 2004. ,
Evidence for expansion of the precuneus in human evolution, Brain Struct Funct, vol.222, issue.2, pp.1053-60, 2017. ,
Human prefrontal cortex: evolution, development, and pathology, Prog Brain Res, vol.195, pp.191-218, 2012. ,
Abnormal functional connectivity strength in first-episode, drug-naïve adult patients with major depressive disorder, Prog Neuropsychopharmacol Biol Psychiatry. 6 sept, p.109759, 2019. ,
Improvement of healthrelated quality of life in depression after transcranial magnetic stimulation in a naturalistic trial is associated with decreased perfusion in precuneus, Health Qual Life Outcomes. 28 juill, vol.10, p.87, 2012. ,
Brain structure alterations in depression: Psychoradiological evidence, CNS Neurosci Ther. 5 mars, vol.24, issue.11, pp.994-1003, 2018. ,
Increased suicide attempts in young depressed patients with abnormal temporal-parietal-limbic gray matter volume, J Affect Disord. août, vol.165, pp.69-73, 2014. ,
Amygdala functional connectivity in female patients with major depressive disorder with and without suicidal ideation ,
, Ann Gen Psychiatry, vol.17, p.37, 2018.
Accelerated rTMS: A Potential Treatment to Alleviate Refractory Depression, Front Psychol, vol.9, 2017. ,
Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression, Brain Stimulat. août, vol.8, issue.4, pp.787-94, 2015. ,
Priming stimulation enhances the effectiveness of low-frequency right prefrontal cortex transcranial magnetic stimulation in major depression, J Clin Psychopharmacol. févr, vol.28, issue.1, pp.52-60, 2008. ,
Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis, JAMA Psychiatry. 1 févr, vol.74, issue.2, pp.143-52, 2017. ,
Coil Design Considerations for Deep Transcranial Magnetic Stimulation, Clin Neurophysiol Off J Int Fed Clin Neurophysiol. juin, vol.125, issue.6, pp.1202-1214, 2014. ,
Cognitive functioning and deep transcranial magnetic stimulation (DTMS) in major psychiatric disorders: A systematic review, J Psychiatr Res. avr, vol.75, pp.107-122, 2016. ,
Challenges in comparing the acute cognitive outcomes of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) vs. electroconvulsive therapy (ECT) in major depression: A systematic review, J Psychiatr Res, vol.91, pp.14-21, 2017. ,
Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder, J Affect Disord, vol.222, pp.14-20, 2017. ,
Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management, J Clin Psychiatry. déc, vol.78, issue.9, pp.1383-94, 2017. ,
Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial, J Affect Disord. 1 mars, vol.173, pp.216-236, 2015. ,
Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people, Pharmacoepidemiol Drug Saf. juin, vol.24, issue.6, pp.637-683, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02006072
The epidemiology of polypharmacy in older adults: register-based prospective cohort study, Clin Epidemiol, vol.10, pp.289-98, 2018. ,
Le risque iatrogène médicamenteux chez le sujet âgé, Gerontol Soc, vol.25, issue.4, pp.93-106, 2002. ,
Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression, J Affect Disord. mai, vol.130, issue.3, pp.466-475, 2011. ,
Therapeutic efficacy and safety of repetitive Transcranial Magnetic ,
, L'Encephale. juin, vol.36, issue.2, pp.105-118, 2010.
Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study, Depress Anxiety, vol.19, issue.4, pp.249-56, 2004. ,
Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, vol.43, issue.11, pp.2231-2239, 2018. ,
Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease, J Neurol. juill, vol.263, issue.7, pp.1442-1450, 2016. ,
High-Frequency Repetitive Transcranial Magnetic Stimulation Can Improve Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study, Neuropsychobiology, vol.73, issue.3, pp.169-77, 2016. ,
Repetitive transcranial magnetic stimulation for the treatment of Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials, PloS One, vol.13, issue.10, p.205704, 2018. ,
The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer's disease: A systematic review and meta-analysis, J Neurol Sci. 15 mars, vol.398, pp.184-91, 2019. ,
Effects of repetitive transcranial magnetic stimulation on improvement of cognition in elderly patients with cognitive impairment: a systematic review and meta-analysis, Int J Geriatr Psychiatry. janv, vol.33, issue.1, pp.1-13, 2018. ,
Neuropsychological changes in melancholic and atypical depression: A systematic review, Neurosci Biobehav Rev. févr, vol.73, pp.309-334, 2017. ,
Interleukin, tumor necrosis factor-? and C-reactive protein profiles in melancholic and nonmelancholic depression: A systematic review, J Psychosom Res, vol.111, pp.58-68, 2018. ,
Atypical depression and nonatypical depression: Is HPA axis function a biomarker? A systematic review, J Affect Disord, vol.233, pp.45-67, 2018. ,
Depressive subtypes in an elderly cohort identified using latent class analysis, J Affect Disord, vol.15, pp.123-153, 2017. ,
Identifying Depressive Subtypes in a Large Cohort Study: Results From the Netherlands Study of Depression and Anxiety (NESDA), J Clin Psychiatry. 15 déc, vol.71, issue.12, pp.1582-1591, 2010. ,
Subtypes of treatment-resistant depression determined by a latent class analysis in a Chinese clinical population, J Affect Disord. 15 avr, vol.249, pp.82-91, 2019. ,
Problems with latent class analysis to detect data-driven subtypes of depression, Mol Psychiatry, vol.23, issue.3, pp.495-501, 2018. ,
The use of latent class analysis for identifying subtypes of depression: A systematic review, Psychiatry Res, vol.266, pp.228-274, 2018. ,
Restingstate connectivity biomarkers define neurophysiological subtypes of depression, Nat Med. janv, vol.23, issue.1, pp.28-38, 2017. ,